Sorcero NIH STRIDES  

Sorcero NIH STRIDES

Sorcero is an AI-powered platform used by major pharmaceutical and biotech companies to analyze and improve their scientific engagement efforts. It helps medical affairs teams work more efficiently, gather evidence, and adjust their strategies based on real-time insights across various therapeutic areas.

Step 1 of 4

Sorcero MIM – Medical Insights Management

Generate Actionable Insights Faster & Easier from Your Key Stakeholders

Sorcero MIM unifies and organizes your structured and unstructured medical data in a single,
collaborative platform. Through the Instant Insights Engine – MIM’s AI-powered conversational
interface – teams can easily query their data using simple language, mirroring the experience of
chatting with an expert colleague. Now, Medical Affairs teams can ask complex medical
questions and instantly receive high-quality answers rooted in real data to guide strategy and
respond to KOL needs faster than ever before.

  • Instant Insights – 18X Faster
    Generate actionable medical insights via real-time dashboards and reports, instead of 3-9 month manual processes
  • Uncover New Insights and Trends - 300% More Insights
    Sorcero MIM ingests and enriches all omnichannel data to surface 300%* more validated medical insights
  • Unify Medical Data Automatically – 72% More Efficient
    Leverage AI for near real-time data processing to improve efficiency by 72%

Step 2 of 4

Sorcero IPM – Intelligent Publications Management

Monitor Products, Competitive Intelligence, & Extract Evidence at Scale

Sorcero IPM pulls together content from 20+ medical research resources into the largest
publication analytics dashboard, organizing and structuring this content according to the medical
terms, concepts, and trends most relevant to your organization. Now, teams can instantly find
evidence grounded in real-world data and monitor evolving trends across product sentiment,
competition, and safety.

  • Largest Industry Content Dataset – 259M+
    Our AI-powered monitoring tool pulls together content from 20+ medical publication resources to deliver the largest industry dataset.
  • Extract Evidence Faster – 88% Reduction
    Replace outsourced intelligence, reviews and reports. Real-world, published results showing an 88% reduction in time to review data and extract evidence.
  • Improve Accuracy & Productivity – 8.3X
    Increase your team’s accuracy and productivity by 8.3x to identify and most relevant evidence on your competitor’s and portfolio products.

Step 3 of 4

Sorcero PLS – Patient Lay Summaries

Generate Patient-Accessible Scientific Evidence at Scale

Sorcero PLS provides teams with a medically intelligent plain language summarization service,
enabling organizations to scale output. Sorcero leverages medically tuned AI to rapidly generate
high-quality and readable first drafts for teams to further refine.

  • Quantifiably More Accessible – 600% Larger Audience
    Sorcero AI-generated plain language content is 600% more readable than manual content and exceeds FDA targets
  • Drive Patient Engagement – 16X Higher Engagement
    Patient-accessible content drives 16x+ higher downloads and impression for product evidence and publications
  • Exponentially Faster – Minutes Not Months
    Receive high-quality first draft in minutes, not months, enabling the coverage of your entire product portfolio and saving thousands of billable hours

Step 4 of 4

Sorcero iSLR – Intelligent Systematic Literature Review

Generate the Highest Grade of Scientific Evidence for Critical Stakeholders

Sorcero iSLR automates the entire systematic literature review process, from initial screening to
inclusion/exclusion to citation tagging. Powered by advanced AI technology, Sorcero iSLR
improves the accuracy of screening decisions, outperforming FDA accuracy thresholds and
human-only workflows. Now, teams can collaborate on literature reviews from a single interface,
enabling more aligned decision-making rooted in real evidence.

  • Accelerate SLRs – 50% Faster
    Conduct 50% faster SLRs, saving 9 months, to accelerate evidence generation and synthesis at scale, faster than traditional manual methods.
  • Beats Human & FDA Accuracy Target – 96.1% Accuracy
    Achieve high-quality SLRs, with 96.1% accuracy of inclusion/exclusion decisions, performance that exceed FDA standards (95%) and human-only workflows (89%).
  • Generate “Gold Standard” Evidence – Influence 78% of Payors Decisions
    Enables thorough, high-quality, and unbiased evidence at scale that influences 78% of insurance payors’ coverage decisions and prior authorization processes.